Description
Osilodrostat (LCI699)is a potent inhibitor of human 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) with IC50 values of 2.5 and 0.7 nM, respectively, and has been approved by the FDA for the treatment of Cushing's disease.
Molecular Formula
C13H10FN3
Smiles
FC1CC(CCC1[C@H]1CCC2CNCN12)C#N
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 50 mg/mL (220.03 mM)
Relative Density
1.32 (Predicted)